Profound Medical Corp.
PRN.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.82% | 0.84% | -7.60% | 3.50% | -3.13% |
| Total Depreciation and Amortization | -6.25% | 5.94% | 77.51% | 61.24% | 18.83% |
| Total Amortization of Deferred Charges | -- | -- | -85.00% | -92.50% | -- |
| Total Other Non-Cash Items | -39.95% | -56.69% | -48.62% | -47.74% | -43.45% |
| Change in Net Operating Assets | 28.08% | 341.82% | 602.54% | 121.51% | 139.73% |
| Cash from Operations | -24.97% | -0.96% | -11.91% | 3.54% | 10.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -71.50% | -196.42% | -188.16% | -164.53% | -161.12% |
| Issuance of Common Stock | 69.15% | 2,228.62% | 760.90% | 710.49% | 764.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -63.31% | -- | -1,147.65% | -1,147.65% | -1,147.65% |
| Cash from Financing | 69.54% | 2,892.84% | 109.33% | 108.19% | 115.23% |
| Foreign Exchange rate Adjustments | -282.76% | -697.75% | -352.38% | -2,184.69% | 78.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 391.19% | 241.35% | 48.33% | 62.78% | 89.47% |